Member Info for Jimzi

Wake up - POLB down 9.5% within the first 30 mins?

If you can't work it out, shouldn't hold AIMers

Added 100k sb at 20.61. Nothing at all has changed apart from a 300% rise in hot air

Doesn't really matter which way round he did it and of course, repayment of a loan is a "net cash balance" to TB - did you expect him to rip up the loan agreement?

Yes, that thought had crossed my mind - suppose it depends on the time gap between his last sale there and the placing decision but defo a bit close to the wind!

The sales have only ever been the repayment of loan shares from 2015 CL agreement - hence 30% unchanged along with the 5.5% of MS

He seems to mess about with BRH and RMS but not here - at 11m mcap, probably why.
https://www.imagingbiometrics.com/iq-ai-ltd/?zn_pb_edit=1%2F#eluid87d71e9b

https://www.tipranks.com/stocks/pdsb/forecast

Little minor snippet for you.
Blackrock holding in PSB up from 40k to over 400k - $5m

Not earth shattering

Also reported earnings -0.03 versus estimate of -0.17 - so beat forecast.

The CLNs arose from a legacy corporate event in March 2015. The remaining few are around because he agreed to extend the deadline in the interests of the company.
2019 raise was a placement of 5m shares by Peterhouse in Oct 19.
Bit of research dispels this silly myth of TB being untoward.

Nah - if you read some posts, its peeps paying their bills and / or succumbing to the low volume summer market malaise.
The volume is derisory.

$3m in grants and a mother of a patents a few weeks ago should give comfort.
https://www.healthimaging.com/topics/ai-emerging-technologies/gadolinium-contrast-ai-software-us-patent?utm_source=side_panel_home&utm_medium=side_panel_ai_in_healthcare&utm_campaign=side_panel_traffic
Value?
Does anyone really think that a 75 year old holding 30% of the company - whose smart - is going to accept 6.5p?
He's looking for a whopper payout - not drip feeding sells at this price - that's the peeps here reading this !
A few need to get a grip - or move on if its all too much

"but you seem to think that should be swept under the carpet and all carry on as before like nothing happened."

Sounds spot on.

What are you going "to do" about it? Call an EGM? LOL

“and am slowly loosing patience. C'mon give us some good news for once.”

So many lose money. Investing requires patience- news on small caps is by definition slow- the reward great .

And indeed TB is 75- I’m sure he’s maintained his 30% in his flagship ( as opposed to the opportunist ) holding to lose a ton of cash. After all, the FDA and Mayo clinic are on board.

GL everyone

If you don’t like the ship, the captain or the cruise, your allowed to leave.

But passengers telling a captain what to do , how he should do it and compare it to unrelated ships merits ridicule.

Especially when it’s posted in thousands of words of repetitive posts. Get a life, sell up and stick to SPC - great research btw - because CF was / is there. LOL crety

Leading the field in a new era. Well Phizer is happy.

It’s peeps who have bills to pay selling at the mercy of the mms.
Even before the 140k sell, it was 7.2 to buy 130k
Over 15% difference lol

It’s their money I suppose. But with free float less than 100m, this is what you get

They are all the same figures from months ago

-21m was June.

The lengths peeps go to squeeze the lemon

It’s currently all position traders, many reading this bb .
GL whatever

Having bought over 450k at 70p late May early June

Raj Chawla Bought another 250,000 , reducing the free float further.

As we have just raised £7m at £1.30 post Astra Zeneca news, the mcap ex cash is £16m.

Making your confusion even greater!

With the EMV link up, we are no longer a passive investment company - a very much hands on capital light investment company.

What is lost on a few is that they raised so much at £1.3 when two days before the sp was 70p.
Large value disconnects do not last for ever.

Not bad forecasts by 7 brokers for our anchor investment esp when other bios are not faring well atm.
No sell recommendations.

https://money.cnn.com/quote/forecast/forecast.html?symb=PDSB

The MMs will pay attention to that

LOL - you think they drive the price. What a tool

Well the BOD did say that should the outcomes look promising, IQAI will enlist a team of regulatory experts in attempt to accelerate the time to market, such as the Orphan Drug program.

And The FDA granted Patisiran (Onpattro) orphan drug status and breakthrough therapy designation due to its novel mechanism involving RNA therapy to block the production of an abnormal form of transthyretin. Patisiran received full FDA approval in 2018[21] and its RNA lipid nanoparticle drug delivery system was later used in the Pfizer–BioNTech COVID-19 vaccine and Moderna RNA vaccines.

And the FDA are fully aware of us.

Seems there are few more selling the family silver to pay Tuesdays bills.
I stand by my post.

wants to keep his %.
Got a better deal than CC